This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Quality Improvement Project - Evaluation of Current Standard of Care for Feeding Practices in the NICU

Sponsored by Baylor College of Medicine

About this trial

Last updated 2 months ago

Study ID

H-26923

Status

Completed

Type

Observational

Placebo

No

Accepting

1+ Years
All Sexes

Trial Timing

Ended 3 months ago

What is this trial about?

Human milk is associated with substantial benefits to infants' health and development, especially in premature infants. Some mothers are unable or unwilling to provide breast milk to their infant. The use of donor human milk as an alternative to cow milk in these infants has risen dramatically in the past year. However, there have been recent reports of hyperphosphatemia and hyponatremia associated with the consumption of donor human milk products. These electrolyte imbalances can lead to concerning symptoms, including headache, nausea, vomiting, altered mental status, coma, seizures, or heart failure. It is important to recognize and appropriately treat these electrolyte disturbances associated with donor human milk to avoid potential nutritional problems.

What are the participation requirements?

Inclusion Criteria

* Premature infants (<37 weeks gestation) with a birth weight less than or equal to 1250 grams.

Exclusion Criteria

* Infants with a birth weight greater than 1250 grams

* Infants transferred from an outside hospital to TCH at greater than 21 days of age

* Infants who do not achieve any enteral feeds by 4 weeks of age

* Infants with major congenital anomalies